Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2015 05/21/2015 05/22/2015 05/26/2015 05/27/2015 Date
9.05(c) 8.84(c) 9.07(c) 8.96(c) 9 Last
2 485 708 4 601 794 2 855 434 2 485 224 830 420 Volume
+0.33% -2.32% +2.60% -1.21% +0.45% Change
More quotes
Financials ($)
Sales 2015 144 M
EBIT 2015 -190 M
Net income 2015 -199 M
Finance 2015 43,9 M
Yield 2015 -
Sales 2016 213 M
EBIT 2016 -144 M
Net income 2016 -143 M
Debt 2016 26,9 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 11,5x
EV / Sales 2016 8,05x
Capitalization 1 690 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788.The company was founded... 
Sector
Pharmaceuticals
Calendar
05/31 | 09:00amPresentation
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
05/21 ARIAD PHARMACEUTICALS : to Present at the Jefferies 2015 Global Healthcare Confe..
05/21 ARIAD PHARMACEUTICALS : Sets Data Presentations at the 2015 ASCO Annual Meeting
05/18 ARIAD PHARMACEUTICALS : Schedules Data Presentations at the 2015 ASCO Annual Mee..
05/15 ARIAD PHARMACEUTICALS : Patent Issued for Methods and Compositions for the Synth..
05/14 ARIAD PHARMACEUTICALS : Reports First Quarter 2015 Financial Results and Progres..
05/14 ARIAD PHARMACEUTICALS : Announces Data Presentations at the 2015 ASCO Annual Mee..
05/13 ARIAD PHARMACEUTICALS : Posts 1Q 2015 Financial Results and Progress on Strategi..
05/11 ARIAD PHARMACEUTICALS : Reports Commercial Distribution Pact for Iclusig (ponati..
More news
Sector news : Biopharmaceuticals
10:55a OPKO HEALTH : to Present at the Jefferies 2015 Healthcare Conference
10:46a ELI LILLY : Lilly Sends Employees to Serve in Vulnerable Communities around the ..
09:55aDJRetrophin Sells FDA Voucher to Sanofi
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/07 ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q1 2015 Results - Earnings C..
05/07 Ariad Pharma reports Q1 results
05/07 ARIAD Pharmaceuticals (ARIA) Q1 2015 Results - Earnings Call Webcast
05/07 ARIAD Pharmaceuticals misses by $0.01, misses on revenue
05/06 Notable earnings before Thursday?s open


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions